By staff writers

July 26, 2018 -- Biotechnology firm RadioMedix and Isotopen Technologien München (ITM) subsidiary Isotope Technologies Garching have signed an agreement to manufacture and supply germanium-68 (Ge-68) and gallium-68 (Ga-68) generators.

The generators will be produced at RadioMedix's Spica radiopharmaceutical manufacturing facility in Houston. Gallium-68 is used in PET imaging to diagnose prostate cancer and neuroendocrine tumors, and it is produced using Ge-68/Ga-68 generators, the company said.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking